Longevity News

Spirulina‑mediated silver nanoparticles induce apoptosis and autophagy in Caco‑2 colorectal cancer cells

Source: Nature - Biotechnology • Published: 26 Aug 2026, 00:00

Spirulina‑mediated silver nanoparticles induce apoptosis and autophagy in Caco‑2 colorectal cancer cells

A study reports green synthesis of silver nanoparticles using a microalga extract and examines their effects on human colon cancer cells, focusing on cell death pathways.

Key Takeaways
  • Biosynthesized silver nanoparticles measured 10–25 nm with a zeta potential of −19.8 mV
  • Nanoparticles showed an IC50 of 6.25 µg/mL against Caco-2 cells after 72 hours
  • Treatment upregulated Bax, Beclin-1, and ATG5 while downregulating Bcl-2, indicating apoptosis and autophagy activation
Read Original Source

Continue exploring

Related longevity signals

Nature - BiotechnologyDevelopment of organic–inorganic hybrid nanoparticles for biomedical applicationsA Focus Review summarizes design principles and biomedical uses of supramolecular organic–inorganic hybrid nanogels built from self-assembling polysaccharides and nanoparticles.Nature - BiotechnologyXenoreduced generation of oral keratinocytes from induced pluripotent stem cells derived from adult human fibroblasts for oral mucosal regenerationDescribes a xenoreduced extracellular matrix protocol that differentiates adult fibroblast–derived iPSCs into oral keratinocyte-like cells for mucosal tissue regeneration.Nature - BiotechnologyVirus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cellsA methods-focused article describing a virus-like particle toolkit for delivering diverse CRISPR edits and enabling pooled functional genomics in primary human myeloid cells.Nature - BiotechnologyTunable polymers for polymer–lipid hybrid nanoparticles facilitate controlled organ-selective RNA deliveryTunable polymer–lipid hybrid nanoparticles: a research article about designing customizable delivery materials to direct RNA therapies to specific organs, showing adaptable formulation strategies and broad therapeutic compatibility.